Evaluation	Evaluation	NN	B-NP	O		0	10
of	of	IN	B-PP	O		11	13
antibacterial	antibacterial	JJ	B-NP	O		14	27
activity	activity	NN	I-NP	O		28	36
of	of	IN	B-PP	O		37	39
synthetic	synthetic	JJ	B-NP	O		40	49
aliphatic	aliphatic	JJ	I-NP	O		50	59
and	and	CC	I-NP	O		60	63
aromatic	aromatic	JJ	I-NP	O		64	72
monoacylglycerols	monoacylglycerol	NNS	I-NP	O		73	90
.	.	.	O	O		90	91

The	The	DT	B-NP	O		92	95
antibacterial	antibacterial	JJ	I-NP	O		96	109
activity	activity	NN	I-NP	O		110	118
of	of	IN	B-PP	O		119	121
synthetic	synthetic	JJ	B-NP	O		122	131
aliphatic	aliphatic	JJ	I-NP	O		132	141
and	and	CC	I-NP	O		142	145
aromatic	aromatic	JJ	I-NP	O		146	154
monoacylglycerols	monoacylglycerol	NNS	I-NP	O		155	172
(	(	(	O	O		173	174
MAGs	MAG	NNS	B-NP	B-protein		174	178
)	)	)	O	O		178	179
was	be	VBD	B-VP	O		180	183
studied	study	VBN	I-VP	O		184	191
against	against	IN	B-PP	O		192	199
two	two	CD	B-NP	O		200	203
human	human	JJ	I-NP	O		204	209
pathogens	pathogen	NNS	I-NP	O		210	219
:	:	:	O	O		219	220
Staphylococcus aureus	Staphylococcus_aureus	NNP	B-NP	O		221	242
and	and	CC	I-NP	O		243	246
Escherichia coli	Escherichia_coli	NNP	I-NP	O		247	263
.	.	.	O	O		263	264

The	The	DT	B-NP	O		265	268
active	active	JJ	I-NP	O		269	275
compounds	compound	NNS	I-NP	O		276	285
inhibited	inhibit	VBD	B-VP	O		286	295
selectively	selectively	RB	B-ADVP	O		296	307
S. aureus	S._aureus	NNP	B-NP	O		308	317
.	.	.	O	O		317	318

The	The	DT	B-NP	O		319	322
most	most	RBS	I-NP	O		323	327
active	active	JJ	I-NP	O		328	334
compounds	compound	NNS	I-NP	O		335	344
amongst	amongst	IN	B-PP	O		345	352
them	them	PRP	B-NP	O		353	357
were	be	VBD	B-VP	O		358	362
those	those	DT	B-NP	O		363	368
with	with	IN	B-PP	O		369	373
medium	medium	NN	B-NP	B-protein		374	380
size	size	NN	I-NP	I-protein		381	385
aliphatic	aliphatic	JJ	I-NP	I-protein		386	395
chain	chain	NN	I-NP	I-protein		396	401
and	and	CC	O	O		402	405
aromatic	aromatic	JJ	B-NP	O		406	414
MAGs	MAG	NNS	I-NP	O		415	419
with	with	IN	B-PP	O		420	424
electron	electron	NN	B-NP	O		425	433
withdrawing	withdraw	VBG	B-VP	O		434	445
substituents	substituent	NNS	B-NP	O		446	458
at	at	IN	B-PP	O		459	461
the	the	DT	B-NP	O		462	465
aryl	aryl	NN	I-NP	O		466	470
ring	ring	NN	I-NP	O		471	475
.	.	.	O	O		475	476

The	The	DT	B-NP	O		477	480
introduction	introduction	NN	I-NP	O		481	493
of	of	IN	B-PP	O		494	496
one	one	CD	B-NP	O		497	500
or	or	CC	I-NP	O		501	503
two-carbon	two-carbon	NN	I-NP	O		504	514
spacer	spacer	NN	I-NP	O		515	521
between	between	IN	B-PP	O		522	529
the	the	DT	B-NP	O		530	533
aryl	aryl	NN	I-NP	O		534	538
ring	ring	NN	I-NP	O		539	543
and	and	CC	O	O		544	547
the	the	DT	B-NP	O		548	551
carboxylic	carboxylic	JJ	I-NP	O		552	562
function	function	NN	I-NP	O		563	571
did	do	VBD	B-VP	O		572	575
not	not	RB	I-VP	O		576	579
influence	influence	VB	I-VP	O		580	589
antibacterial	antibacterial	JJ	B-NP	O		590	603
effectiveness	effectiveness	NN	I-NP	O		604	617
.	.	.	O	O		617	618

